Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes.
Rachel M BurdorfShuntai ZhouClaire AmonNathan LongCollin S HillLily AdamsGerald TeghaMaganizo B ChagomeranaAllan JumbeMadalitso MaliwichiShaphil WallieYijia LiRonald SwanstromMina C HosseinipourPublished in: The Journal of infectious diseases (2024)
Using accurate NGS for DRM detection may benefit an additional 10% of patients by identifying low-frequency K103N mutations.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- hiv infected
- hepatitis c virus
- hiv positive
- hiv aids
- ejection fraction
- end stage renal disease
- newly diagnosed
- prognostic factors
- type diabetes
- mass spectrometry
- adipose tissue
- patient reported outcomes
- loop mediated isothermal amplification
- label free
- sensitive detection
- weight loss
- quantum dots